Antithrombotic therapy recommendations in the European Society of Cardiology Guidelines : how robust are the randomized controlled trials underpinning them?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10451/47521 |
Resumo: | © 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG |
id |
RCAP_6967a58e5bd4fe4ffbbfca174a6e4841 |
---|---|
oai_identifier_str |
oai:repositorio.ul.pt:10451/47521 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Antithrombotic therapy recommendations in the European Society of Cardiology Guidelines : how robust are the randomized controlled trials underpinning them?Anticoagulant agentsAntiplatelet agentsCardiovascular systemFibrinolytic therapyHealth planning recommendations© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KGIntroduction: Criticisms have been raised against the sole use of p-value in interpreting results from randomized controlled trials (RCTs). Additional tools have been suggested, like the fragility index (FI), a measure of a trial’s robustness/fragility, and derivative measures. The FI is the minimum number of patients who would have to be converted from nonevents to events, in the group with the least events, for a result to lose statistical significance. Objective: This study aimed to evaluate RCT supporting European Society of Cardiology (ESC) guidelines regarding antithrombotics, using the FI and FI-related measures. Methods FI, fragility quotient (FQ), and FI minus LTF lost to follow-up (FI LTF) were calculated for the RCT underpinning recommendations regarding antithrombotic therapy from the updated ESC guidelines. LTF was compared with FI. Results were calculated for the total group of studies, as per guideline and as per recommendation type. Results Overall, 61 studies were included. The median FI was 24.5 (interquartile range [IQR]: 9.0–60.0) and median FQ was 0.0035 (IQR: 0.0019–0.0056). Median FI LTF was 2.0 (IQR: 0.0–38.0). Twenty (32.8%) of the studies had one primary or main safety outcome with LTF exceeding FI. Peripheral arterial disease guideline and chronic coronary syndrome guideline had the lowest (2.5; IQR: 1.8–3.3) and the highest (48.5; IQR: 23.8–73.0) FI, respectively. Conclusion: The median FI suggests robustness of clinical trials evaluating antithrombotic drugs cited in the guidelines, but about one-third of them had LTF larger than FI. This emphasizes the need for assessing trials’ robustness when constructing guidelines.ThiemeRepositório da Universidade de LisboaSantos, Catarina M.Prada, LuísaDavid, CláudioCosta, JoãoFerreira, Joaquim J.Pinto, Fausto J.Caldeira, Daniel2021-04-22T15:17:58Z20212021-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/47521engTH Open. 2021 Apr 14;5(2):e125-e133.10.1055/s-0041-17250432512-9465info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-08T16:50:29Zoai:repositorio.ul.pt:10451/47521Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:59:32.433505Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Antithrombotic therapy recommendations in the European Society of Cardiology Guidelines : how robust are the randomized controlled trials underpinning them? |
title |
Antithrombotic therapy recommendations in the European Society of Cardiology Guidelines : how robust are the randomized controlled trials underpinning them? |
spellingShingle |
Antithrombotic therapy recommendations in the European Society of Cardiology Guidelines : how robust are the randomized controlled trials underpinning them? Santos, Catarina M. Anticoagulant agents Antiplatelet agents Cardiovascular system Fibrinolytic therapy Health planning recommendations |
title_short |
Antithrombotic therapy recommendations in the European Society of Cardiology Guidelines : how robust are the randomized controlled trials underpinning them? |
title_full |
Antithrombotic therapy recommendations in the European Society of Cardiology Guidelines : how robust are the randomized controlled trials underpinning them? |
title_fullStr |
Antithrombotic therapy recommendations in the European Society of Cardiology Guidelines : how robust are the randomized controlled trials underpinning them? |
title_full_unstemmed |
Antithrombotic therapy recommendations in the European Society of Cardiology Guidelines : how robust are the randomized controlled trials underpinning them? |
title_sort |
Antithrombotic therapy recommendations in the European Society of Cardiology Guidelines : how robust are the randomized controlled trials underpinning them? |
author |
Santos, Catarina M. |
author_facet |
Santos, Catarina M. Prada, Luísa David, Cláudio Costa, João Ferreira, Joaquim J. Pinto, Fausto J. Caldeira, Daniel |
author_role |
author |
author2 |
Prada, Luísa David, Cláudio Costa, João Ferreira, Joaquim J. Pinto, Fausto J. Caldeira, Daniel |
author2_role |
author author author author author author |
dc.contributor.none.fl_str_mv |
Repositório da Universidade de Lisboa |
dc.contributor.author.fl_str_mv |
Santos, Catarina M. Prada, Luísa David, Cláudio Costa, João Ferreira, Joaquim J. Pinto, Fausto J. Caldeira, Daniel |
dc.subject.por.fl_str_mv |
Anticoagulant agents Antiplatelet agents Cardiovascular system Fibrinolytic therapy Health planning recommendations |
topic |
Anticoagulant agents Antiplatelet agents Cardiovascular system Fibrinolytic therapy Health planning recommendations |
description |
© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-04-22T15:17:58Z 2021 2021-01-01T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10451/47521 |
url |
http://hdl.handle.net/10451/47521 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
TH Open. 2021 Apr 14;5(2):e125-e133. 10.1055/s-0041-1725043 2512-9465 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Thieme |
publisher.none.fl_str_mv |
Thieme |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799134541096419328 |